Αποτελέσματα Αναζήτησης
15 Μαΐ 2020 · Maintenance therapy consists of liberal use of emollients and daily bathing with soap-free cleansers. Use of topical corticosteroids is the first-line treatment for atopic dermatitis flare-ups.
- Management of Atopic Dermatitis: Guideline from the American ... - AAFP
Key Points for Practice. • An essential nonpharmacologic...
- Management of Atopic Dermatitis: Guidelines from the AAD - AAFP
Topical therapy is the mainstay of treatment, and in severe...
- Management of Atopic Dermatitis: Guideline from the American ... - AAFP
1 Δεκ 2014 · Key Points for Practice. • An essential nonpharmacologic component of treatment is regular application of moisturizers after bathing. • If the atopic dermatitis has not responded to good...
Topical therapy is the mainstay of treatment, and in severe cases, it is often combined with systemic therapy. This guideline from the American Academy of Dermatology provides information about...
These evidence-based recommendations address optimal use of (1) topical treatments (barrier moisturization devices, corticosteroids, calcineurin inhibitors, PDE4 inhibitors [crisaborole], topical JAK inhibitors, occlusive [wet wrap] therapy, adjunctive antimicrobials, application frequency, maintenance therapy), (2) dilute bleach baths, (3) diet...
For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered. Multiple biologic therapies and Janus kinase (JAK)inhibitors have been approved since 2014 to treat AD.
25 Σεπ 2014 · This guideline addresses the treatment of pediatric and adult atopic dermatitis (AD; atopic eczema) of all severities. The treatment of other forms of eczematous dermatitis is outside the scope of this document.
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024 Mar;132 (3):274-312. doi: 10.1016/j.anai.2023.11.009. Epub 2023 Dec 18.
